WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome

被引:735
作者
Staub, O
Dho, S
Henry, PC
Correa, J
Ishikawa, T
McGlade, J
Rotin, D
机构
[1] HOSP SICK CHILDREN, DIV RESP RES, TORONTO, ON M5G 1X8, CANADA
[2] AMGEN RES INST, TORONTO, ON, CANADA
关键词
epithelial NA(+) channel; Nedd4; PY motif; ubiquitin ligase; WW domains;
D O I
10.1002/j.1460-2075.1996.tb00593.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amiloride-sensitive epithelial sodium channel (ENaC) plays a major role in sodium transport in kidney and other epithelia, and in regulating blood pressure. The channel is composed of three submits (alpha beta gamma) each containing two proline-rich sequences (P1 and P2) at its C-terminus, The P2 regions in human beta and gamma ENaC, identical to the rat beta gamma rENaC, mere recently shown to be deleted in patients with Liddle's syndrome (a hereditary form of hypertension), leading to hyperactivation of the channel. Using a yeast two-hybrid screen, we have now identified the rat homologue of Nedd4 (rNedd4) as the binding partner for the P2 regions of beta and gamma rENaC. rNedd4 contains a Ca2+ lipid binding (CaLB or C2) domain, three WW domains and a ubiquitin ligase (Hect) domain, Our yeast two-hybrid and in vitro binding studies revealed that the rNedd4-WW domains mediate this association by binding to the P2 regions, which include the PY moths (XPPXY) of either beta rENaC (PPPNY) or gamma rENaC (PPPRY). SH3 domains were unable to bind these sequences. Moreover, mutations to Ala of Pro616 or Tyr618 within the beta rENaC P2 sequence (to PPANY or PPPNA, respectively), recently described in Liddle's patients, led to abrogation of rNedd4-WW binding. Nedd4-WW domains also bound to the proline-rich C-terminus (containing the sequence PPPAY) of alpha rENaC, and endogenous Nedd4 co-immunoprecipitated with alpha rENaC expressed in MDCK cells. These results demonstrate that the WW domains of rNedd4 bind to the PY moths deleted from beta or gamma ENaC in Liddle's syndrome patients, and suggest that Nedd4 may be a regulator (suppressor) of the epithelial Na+ channel.
引用
收藏
页码:2371 / 2380
页数:10
相关论文
共 54 条
  • [11] THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY
    CIECHANOVER, A
    [J]. CELL, 1994, 79 (01) : 13 - 21
  • [12] A NOVEL ARACHIDONIC ACID-SELECTIVE CYTOSOLIC PLA2 CONTAINS A CA2+-DEPENDENT TRANSLOCATION DOMAIN WITH HOMOLOGY TO PKC AND GAP
    CLARK, JD
    LIN, LL
    KRIZ, RW
    RAMESHA, CS
    SULTZMAN, LA
    LIN, AY
    MILONA, N
    KNOPF, JL
    [J]. CELL, 1991, 65 (06) : 1043 - 1051
  • [13] MODULAR BINDING DOMAINS IN SIGNAL-TRANSDUCTION PROTEINS
    COHEN, GB
    REN, RB
    BALTIMORE, D
    [J]. CELL, 1995, 80 (02) : 237 - 248
  • [14] MULTIPLE, DISTINCT FORMS OF BOVINE AND HUMAN PROTEIN-KINASE-C SUGGEST DIVERSITY IN CELLULAR SIGNALING PATHWAYS
    COUSSENS, L
    PARKER, PJ
    RHEE, L
    YANGFENG, TL
    CHEN, E
    WATERFIELD, MD
    FRANCKE, U
    ULLRICH, A
    [J]. SCIENCE, 1986, 233 (4766) : 859 - 866
  • [15] CELL-SPECIFIC EXPRESSION OF EPITHELIAL SODIUM-CHANNEL ALPHA-SUBUNITS, BETA-SUBUNITS, AND GAMMA-SUBUNITS IN ALDOSTERONE-RESPONSIVE EPITHELIA FROM THE RAT - LOCALIZATION BY IN-SITU HYBRIDIZATION AND IMMUNOCYTOCHEMISTRY
    DUC, C
    FARMAN, N
    CANESSA, CM
    BONVALET, JP
    ROSSIER, BC
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 127 (06) : 1907 - 1921
  • [16] 2 BINDING ORIENTATIONS FOR PEPTIDES TO THE SRC SH3 DOMAIN - DEVELOPMENT OF A GENERAL-MODEL FOR SH3-LIGAND INTERACTIONS
    FENG, SB
    CHEN, JK
    YU, HT
    SIMON, JA
    SCHREIBER, SL
    [J]. SCIENCE, 1994, 266 (5188) : 1241 - 1247
  • [17] MOLECULAR-PROPERTIES OF EPITHELIAL, AMILORIDE-BLOCKABLE NA+ CHANNELS
    GARTY, H
    [J]. FASEB JOURNAL, 1994, 8 (08) : 522 - 528
  • [18] GAWLER DJ, 1995, ONCOGENE, V10, P817
  • [19] SYNAPTOTAGMIN-I - A MAJOR CA2+ SENSOR FOR TRANSMITTER RELEASE AT A CENTRAL SYNAPSE
    GEPPERT, M
    GODA, Y
    HAMMER, RE
    LI, C
    ROSAHL, TW
    STEVENS, CF
    SUDHOF, TC
    [J]. CELL, 1994, 79 (04) : 717 - 727
  • [20] GUARENTE L, 1983, METHOD ENZYMOL, V101, P181